Calvert Paula M, Frucht Harold
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Ann Intern Med. 2002 Oct 1;137(7):603-12. doi: 10.7326/0003-4819-137-7-200210010-00012.
Colon cancer is a common disease that can be sporadic, familial, or inherited. Recent advances have contributed to the understanding of the molecular basis of these various patterns of colon cancer. Germline genetic mutations are the basis of inherited colon cancer syndromes; an accumulation of somatic mutations in a cell is the basis of sporadic colon cancer; and, in Ashkenazi Jewish persons, a mutation that was previously thought to be a polymorphism may cause familial colon cancer. Mutations of three different classes of genes have been described in colon cancer etiology: oncogenes, suppressor genes, and mismatch repair genes. Knowledge of many of the specific mutations responsible for colon carcinogenesis allows an understanding of the phenotypic manifestations observed and forms the basis of genetic testing for inherited disease. Although genetic testing is possible and available, it is only an adjunct to the clinical management of persons at risk for colon cancer and patients with colon cancer. As a result of advances in the understanding of the molecular causes of colon cancer and the availability of colon cancer screening methods such as colonoscopy, it should be possible to prevent the vast majority of colon cancer in our society. Practicing clinicians should recognize the patterns of clinical colon cancer, understand its causes, and be able to use genetic testing and endoscopic screening for prevention.
结肠癌是一种常见疾病,可呈散发性、家族性或遗传性。最近的进展有助于人们理解这些不同类型结肠癌的分子基础。种系基因突变是遗传性结肠癌综合征的基础;细胞中体细胞突变的积累是散发性结肠癌的基础;在阿什肯纳兹犹太人中,一种以前被认为是多态性的突变可能导致家族性结肠癌。在结肠癌病因学中已描述了三类不同基因的突变:癌基因、抑癌基因和错配修复基因。了解许多导致结肠癌发生的特定突变,有助于理解所观察到的表型表现,并构成遗传性疾病基因检测的基础。尽管基因检测可行且可用,但它只是结肠癌高危人群和结肠癌患者临床管理的辅助手段。由于在理解结肠癌分子病因方面取得的进展以及结肠镜检查等结肠癌筛查方法的出现,在我们的社会中预防绝大多数结肠癌应该是可行的。执业临床医生应认识到临床结肠癌的模式,了解其病因,并能够利用基因检测和内镜筛查进行预防。